Related Experiment Video
Updated: May 3, 2026

Müller Glia Cell Activation in a Laser-induced Retinal Degeneration and Regeneration Model in Zebrafish
Published on: October 27, 2017
GPR40 Attenuates Age-Related Macular Degeneration by Suppressing Retinal Microglial NLRP3 Inflammasome Activation Via
Xin Tan1,2,3, Jianshu Kang1,2, Hongkun Zhao1,2
1Department of Ophthalmology, Yunnan Eye Institute & Key Laboratory of Yunnan Province, Yunnan Eye Disease Clinical Medical Center, Affiliated Hospital of Yunnan University, Yunnan University, Kunming, China.
Abstract:
Retinal neuroinflammation is a key pathological feature of age-related macular degeneration (AMD), primarily driven by aberrant microglial cell activation. The expression and role of G-protein-coupled receptor 40 (GPR40), in AMD remain unclear. To investigate this pathology, we established a sodium iodate-induced mouse model of non-exudative AMD and performed in vitro experiments using LPS-stimulated microglial cells. The results showed that activation of the GPR40 receptor significantly promoted the polarization of microglial cells from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype, effectively inhibiting neuroinflammation. Mechanistic studies revealed that GPR40 negatively regulates the ERK signaling pathway, inhibiting NLRP3 inflammasome activation and the release of pro-inflammatory cytokines such as IL-1β and TNF-α. In both in vivo and in vitro experiments, GPR40 activation protected photoreceptors by suppressing neuroinflammation caused by excessive microglial activation. In conclusion, this study reveals, for the first time, the critical role of GPR40 in regulating retinal neuroinflammation and its molecular mechanism. It highlights the potential therapeutic value of targeting the GPR40-ERK signaling axis to control the neuroinflammatory cascade and delay the progression of AMD and other retinal degenerative diseases.
Insights
G-protein-coupled receptor 40 (GPR40) activation shifts microglial cells to an anti-inflammatory state, protecting retinal cells. Targeting the GPR40-ERK pathway may treat age-related macular degeneration (AMD) and other retinal diseases.
Area of Science:
- Ophthalmology
- Neuroscience
- Immunology
Background:
- Retinal neuroinflammation, driven by microglial activation, is central to age-related macular degeneration (AMD).
- The role of G-protein-coupled receptor 40 (GPR40) in AMD pathogenesis is currently unknown.
Purpose of the Study:
- To investigate the role and mechanism of GPR40 in regulating retinal neuroinflammation in AMD.
Main Methods:
- Established a sodium iodate-induced mouse model of non-exudative AMD.
- Utilized in vitro experiments with lipopolysaccharide (LPS)-stimulated microglial cells.
- Analyzed GPR40's effect on microglial polarization, ERK signaling, NLRP3 inflammasome activation, and cytokine release.
Main Results:
- GPR40 activation promoted M2 anti-inflammatory microglial polarization, suppressing neuroinflammation.
- GPR40 negatively regulated the ERK signaling pathway, inhibiting NLRP3 inflammasome activation and pro-inflammatory cytokine release (IL-1β, TNF-α).
- GPR40 activation protected photoreceptors from neuroinflammation in vivo and in vitro.
Conclusions:
- GPR40 plays a critical role in modulating retinal neuroinflammation via the GPR40-ERK signaling axis.
- Targeting GPR40 offers a potential therapeutic strategy for AMD and other retinal degenerative diseases.
More Related Videos
10:24Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report
Published on: February 12, 2018
11:20Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity